Socio-demographic processes, increased economic instability, epidemiological transitions and disproportionate access to health care present serious challenges to the health care systems of major global powers, especially to the medication supply. In many countries, inadequate regulation of the health sector, in particular in the pharmaceutical area, leads to serious human rights’ violations. At the same time ensuring the safety of drugs is the basis for the full exercise of the human right to health, which is impossible to achieve without effective international cooperation. Enjoyment of the right to the highest attainable standard of health, enshrined in the main international human rights documents, in particular by providing access to medicines is only possible on the basis of an effective and integrated regulation system and in compliance with recognized international standards, as well as national and regional priorities.
THE ROLE OF PHARMACEUTICAL REGULATION IN IMPLEMENTATION OF THE HUMAN RIGHT TO THE HIGHEST ATTAINABLE STANDARD OF HEALTH
